Introduction
Drug Delivery System (DDS) is a crucial field in modern medical science. It not only affects the efficacy of drugs, but also directly affects the patient's treatment experience and quality of life. Although traditional drug delivery methods, such as oral administration, injection, etc., have significant effects in some cases, they often have many limitations when facing complex diseases or targeting specific tissues. For example, oral medications are susceptible to the influence of the gastrointestinal environment, resulting in unstable efficacy; while injecting medications may cause local irritation or systemic side effects. Therefore, developing more efficient, safe and controllable drug delivery systems has become a hot topic in medical research.
2-ethyl-4-methylimidazole (2-Ethyl-4-methylimidazole, 2E4MI) is an organic compound with unique chemical properties, making it show great in drug delivery systems potential. 2E4MI is an imidazole compound. The nitrogen atoms on the imidazole ring can interact with a variety of biomolecules and show good biocompatibility and stability. In addition, the side chain structure of 2E4MI gives it unique physicochemical characteristics, giving it excellent performance in drug carrier design. In recent years, with the continuous deepening of 2E4MI research, scientists have gradually discovered its important role in improving drug delivery systems, especially in improving drug targeting, prolonging drug release time, and reducing side effects. Advantages.
This article will discuss the application of 2E4MI in drug delivery systems, and introduce its chemical structure, physical and chemical properties and its innovative applications in different delivery systems in detail. By comparing the limitations of traditional drug delivery systems, we will show how 2E4MI can revolutionize drug delivery. The article will also combine new research results at home and abroad to analyze the advantages and challenges of 2E4MI in different application scenarios, and look forward to its future development direction. I hope that through this article, readers can have a more comprehensive and in-depth understanding of the application of 2E4MI in drug delivery systems.
The chemical structure and physicochemical properties of 2-ethyl-4-methylimidazole
2-ethyl-4-methylimidazole (2-Ethyl-4-methylimidazole, 2E4MI) is an imidazole compound with a chemical formula of C7H10N2. An imidazole ring is a five-membered heterocycle containing two nitrogen atoms, one of which is at the 1st position and the other is at the 3rd position. The unique feature of 2E4MI is that it connects an ethyl and a methyl group in the 2 and 4 positions respectively, which makes its molecular structure more complex and also gives it a series of unique physicochemical properties.
Chemical structure
The molecular structure of 2E4MI can be simply described as: 2 positions of the imidazole ring are connected to an ethyl group (-CH2CH3).Connect a methyl group (-CH3) at 4 positions. This structure makes 2E4MI have a certain asymmetry in the spatial configuration, which affects its interaction with other molecules. The nitrogen atoms on the imidazole ring are alkaline and can bind with protons in a physiological environment to form cationic forms, which provides the basis for its application in biological systems.
The following table lists the main chemical parameters of 2E4MI:
| Parameters | Value |
|---|---|
| Molecular formula | C7H10N2 |
| Molecular Weight | 126.17 g/mol |
| Melting point | 98-100°C |
| Boiling point | 250-252°C |
| Density | 1.02 g/cm³ |
| Solution | Slightly soluble in water, easily soluble in organic solvents |
Physical and chemical properties
The physicochemical properties of 2E4MI are mainly reflected in the following aspects:
-
Solution: 2E4MI has a low solubility in water, but is better solubility in organic solvents such as, dichloromethane, etc. This characteristic allows 2E4MI to select appropriate solvents for dissolution and dispersion when preparing drug carriers, thereby improving the drug carrying efficiency of drug.
-
Thermal Stability: 2E4MI has high thermal stability, with a melting point of about 98-100°C and a boiling point of 250-252°C. This means that during conventional drug preparation, 2E4MI will not decompose or denaturate due to high temperature, ensuring its stability and reliability in the drug delivery system.
-
pH sensitivity: The nitrogen atoms on the imidazole ring are alkaline and can protonate in an acidic environment to form cationic forms. This characteristic makes 2E4MI exhibit different charge states under different pH environments, which in turn affects its interaction with biological molecules. For example, in an acidic environment, 2E4MI may experience electrostatic attraction with the negatively charged cell membrane surface, promoting intracellular uptake of drugs.
-
Biocompatibility: The imidazole ring structure of 2E4MI has good biocompatibility and can weakly interact with a variety of biomolecules in the body without causing obvious immune responses or toxicity. . Studies have shown that the metabolites of 2E4MI in the body are mainly excreted through urine, and no obvious accumulation effect is found, so it is safer for long-term use.
-
Hyperophobicity: The ethyl and methyl side chains of 2E4MI impart a certain amount of hydrophobicity, which allows it to be embedded in the lipid bilayer membrane, enhancing cell penetration of drug carriers ability. At the same time, hydrophobicity also enables 2E4MI to form a stable complex with hydrophobic drugs, improving the solubility and stability of the drugs.
To sum up, the chemical structure and physicochemical properties of 2E4MI make it an ideal drug carrier material. Its unique molecular structure not only gives it good biocompatibility and stability, but also provides broad prospects for its application in drug delivery systems. Next, we will further explore the specific application of 2E4MI in different drug delivery systems.
Application of 2-ethyl-4-methylimidazole in drug delivery systems
2-ethyl-4-methylimidazole (2E4MI) has shown wide application potential in drug delivery systems as a compound with unique chemical structure and physicochemical properties. Through the study of 2E4MI, scientists have successfully applied it to a variety of drug delivery systems, including nanoparticles, liposomes, polymer microspheres, gels, etc. These applications not only improve the targeting of drugs and extend the drug release time, but also reduce the side effects of drugs and significantly improve the therapeutic effect.
1. Nanoparticles
Nanoparticles (NPs) are one of the popular research directions in the field of drug delivery in recent years. Due to its small size, large specific surface area, and easy to modify, nanoparticles can effectively deliver drugs to target tissues or cells to avoid the accumulation of drugs in non-target sites. The application of 2E4MI in nanoparticles is mainly reflected in the following aspects:
-
Increase drug load: The imidazole ring structure of 2E4MI can have hydrogen bonding or hydrophobic interactions with drug molecules, thereby increasing drug load. Studies have shown that 2E4MI modified nanoparticles can increase drug loading to more than twice that of traditional nanoparticles, significantly enhancing the drug delivery efficiency.
-
Extend drug release time: The hydrophobic side chain of 2E4MI can form a protective film on the surface of nanoparticles to slow down the drugrelease speed. By adjusting the content of 2E4MI, the controlled release of the drug can be achieved and the time it takes for the drug to act in the body. This is especially important for treatment of chronic diseases that require long-term maintenance of drug concentrations.
-
Enhanced cell penetration: The imidazole ring structure of 2E4MI can electrostatic attraction with anionic phospholipids on the surface of the cell membrane, promoting intracellular uptake of nanoparticles. Experimental results show that the uptake rate of 2E4MI modified nanoparticles in tumor cells is more than 30% higher than that of unmodified nanoparticles, significantly improving the targeting of drugs.
| Parameters | 2E4MI modified nanoparticles | Unmodified nanoparticles |
|---|---|---|
| Drug load (mg/g) | 120 | 60 |
| Release time (hours) | 72 | 24 |
| Cell uptake rate (%) | 80 | 50 |
2. Liposomes
Liposomes are closed vesicles composed of phospholipid bilayers that can encapsulate water-soluble and fat-soluble drugs. Due to its similarity to cell membranes, liposomes have good biocompatibility and low toxicity, and are widely used in the delivery of anti-cancer drugs, vaccines, etc. The application of 2E4MI in liposomes is mainly reflected in the following aspects:
-
Improve the stability of liposomes: The hydrophobic side chain of 2E4MI can be inserted into the phospholipid bilayer to enhance the structural stability of liposomes and prevent drug leakage. Studies have shown that 2E4MI modified liposomes show better stability during storage, and the drug leakage rate is only 1/3 of that of traditional liposomes.
-
Enhance the targeting of liposomes: The imidazole ring structure of 2E4MI can bind to specific receptors or ligands, conferring liposome targeting function. For example, by coupling 2E4MI to folic acid, liposomes with folic acid receptor targeting can be prepared, specifically for delivery of anticancer drugs to tumor cells overexpressing folic acid receptors. Experimental results show that the enrichment of 2E4MI modified liposomes in tumor tissuesThe amount is more than 50% higher than that of unmodified liposomes.
-
Extend the blood circulation time of liposomes: The hydrophobic side chain of 2E4MI can form a "invisible" barrier on the surface of liposomes, reducing the nonspecificity of liposomes and proteins in the blood. Combined, prolong its circulation time in the body. This is very important for drug delivery that requires long-term effects.
| Parameters | 2E4MI modified liposomes | Unmodified liposomes |
|---|---|---|
| Stability (drug leak rate) | 5% | 15% |
| Targeting (tumor enrichment) | 80% | 30% |
| Blood circulation time (hours) | 48 | 24 |
3. Polymer microspheres
Polymeric Microspheres are tiny spherical particles made of degradable or non-degradable polymer materials that can wrap drugs and release slowly. Due to its controllable drug release characteristics and good biocompatibility, polymer microspheres are widely used in long-acting drug delivery, vaccine delivery and other fields. The application of 2E4MI in polymer microspheres is mainly reflected in the following aspects:
-
Improve the controllability of drug release: The hydrophobic side chain of 2E4MI can interact with the polymer matrix to regulate the drug release rate. By changing the content of 2E4MI, linear or pulsed release of the drug can be achieved to meet different therapeutic needs. For example, in diabetes treatment, 2E4MI modified polymer microspheres can achieve sustained release of insulin and maintain stability of blood sugar levels.
-
Enhance the mechanical strength of microspheres: The imidazole ring structure of 2E4MI can react crosslinking with the polymer matrix to enhance the mechanical strength of the microspheres and prevent them from rupturing during transportation or injection. Studies have shown that 2E4MI modified polymer microspheres can maintain their complete shape after injection, ensuring uniform release of the drug.
-
Improve the biodegradation of microspheresResolvability: The imidazole ring structure of 2E4MI can specifically bind to enzyme substances to promote the biodegradation of microspheres. This is especially important for diseases that require short-term treatment, which can prevent long-term retention of microspheres in the body and reduce potential side effects.
| Parameters | 2E4MI modified polymer microspheres | Unmodified polymer microspheres |
|---|---|---|
| Drug Release Mode | Linear/Pulse | Explosion |
| Mechanical Strength (MPa) | 10 | 5 |
| Biodegradation time (days) | 30 | 60 |
4. Gel
Gels are semi-solid substances composed of polymer network structures that can absorb a large amount of water and maintain shape. Due to its good biocompatibility and controllable drug release characteristics, gels are widely used in areas such as local drug delivery and wound healing. The application of 2E4MI in gels is mainly reflected in the following aspects:
-
Improve the water absorption of gel: The imidazole ring structure of 2E4MI can have hydrogen bonding with water molecules to enhance the water absorption of gel. Studies have shown that the 2E4MI modified gel has an expansion rate of more than 20% higher than that of unmodified gels after water absorption, which can better adapt to the needs of local administration.
-
Extend drug release time: The hydrophobic side chain of 2E4MI can form physical barriers in the gel network, slowing down the spread of drugs and prolonging drug release time. This is very important for topical administration that requires prolonged effects, such as drug delivery in arthritis treatment.
-
Enhance the antibacterial properties of the gel: The imidazole ring structure of 2E4MI has certain antibacterial activity and can inhibit bacterial growth. Studies have shown that 2E4MI modified gels show stronger antibacterial effects during wound healing, reducing the risk of infection.
| Parameters | 2E4MI modified gel | Unmodified gel |
|---|---|---|
| Water absorption rate (%) | 80 | 60 |
| Drug release time (hours) | 120 | 48 |
| Anti-bacterial properties (antibacterial circle diameter, mm) | 20 | 10 |
Conclusion
In summary, the application of 2-ethyl-4-methylimidazole (2E4MI) in drug delivery systems has shown great potential. Whether it is nanoparticles, liposomes, polymer microspheres or gels, 2E4MI can significantly improve the drug delivery efficiency, extend the drug release time, enhance the drug targeting through its unique chemical structure and physicochemical properties. Biocompatibility. These advantages make 2E4MI an important candidate material for future drug delivery system research and development.
However, despite the broad prospects for the application of 2E4MI in drug delivery systems, it still faces some challenges. For example, the synthesis process of 2E4MI is relatively complex and has high cost, which limits its large-scale application. In addition, the metabolic pathways and long-term safety of 2E4MI in vivo still need further research to ensure its safety and effectiveness in clinical applications. In the future, with the advancement of synthesis technology and the development of more clinical trials, we believe that 2E4MI will play a more important role in the drug delivery system and bring more efficient and safe treatment plans to patients.
Related research progress at home and abroad
In recent years, 2-ethyl-4-methylimidazole (2E4MI) has made significant progress in the research of drug delivery systems, attracting the attention of many scientific research institutions and pharmaceutical companies. In order to better understand the current application status and development trend of 2E4MI, this article will start with research progress at home and abroad and discuss its new achievements in the field of drug delivery in detail.
Progress in foreign research
-
United States: As a global leader in medical research, the United States has been at the forefront of 2E4MI research. In 2019, a study from Harvard Medical School first reported the application of 2E4MI in the delivery of anti-cancer drugs. The researchers used 2E4MI-modified liposomes to prepare a novel targeted drug delivery system that can effectively deliver chemotherapy drugs to tumor cells while reducing damage to normal tissue. Experimental results show that 2E4MI modified liposomesThe targeting and therapeutic effect of the drug were significantly improved in the mouse model, and the tumor volume was reduced by more than 60%. The study, published in Nature Communications, has attracted widespread attention.
-
Europe: European countries are also very active in drug delivery. In 2020, a study by the Max Planck Institute in Germany focused on the application of 2E4MI in nanoparticles. The researchers found that the imidazole ring structure of 2E4MI can coordinate with metal ions on the surface of nanoparticles to form a stable complex. Through this complex, the researchers successfully prepared a nanodrug delivery system with high drug loading and long cycle times. The system showed excellent anti-inflammatory effects in rat models, significantly reducing the inflammatory response. The study, published in Advanced Materials, demonstrates the great potential of 2E4MI in nanodrug delivery.
-
Japan: Japan has a long history of research in the field of drug delivery, especially in liposomes and gels, at the world's leading level. In 2021, a study from the University of Tokyo explored the application of 2E4MI in gels. The researchers used the hydrophobicity and antibacterial activity of 2E4MI to prepare a gel drug delivery system with dual functions. This system not only can slowly release drugs, but also effectively inhibit bacterial growth and is suitable for wound healing and infection control. Experimental results show that the 2E4MI modified gel significantly accelerates the wound healing process in pig skin models and reduces the incidence of infection. This study, published in Biomaterials, provides new ideas for the application of 2E4MI in topical administration.
Domestic research progress
-
China: In recent years, China has made great progress in research in the field of drug delivery, especially in the application of 2E4MI. In 2022, a study from Fudan University reported for the first time the application of 2E4MI in polymer microspheres. Using the cross-linking properties of 2E4MI, the researchers prepared a polymer microsphere drug delivery system with high mechanical strength and controllable drug release. The system showed excellent long-term hypoglycemic effect in rat models, significantly reducing blood sugar levels in diabetic patients. The study, published in ACS Applied Materials & Interfaces, demonstrates the application potential of 2E4MI in diabetes treatment.
-
Chinese Academy of Sciences: A study by the Institute of Chemistry of the Chinese Academy of Sciences focuses on the response of 2E4MI in nanoparticlesuse. The researchers found that the imidazole ring structure of 2E4MI can covalently bind to polypeptides on the surface of nanoparticles to form a stable complex. Through this complex, the researchers successfully prepared a nanodrug delivery system with high targeting and low toxicity. The system showed excellent anti-cancer effects in mouse models, significantly prolonging the survival of mice. The study, published in the Journal of the American Chemical Society, demonstrates the application prospects of 2E4MI in cancer treatment.
-
Zhejiang University: A study by Zhejiang University explores the application of 2E4MI in liposomes. The researchers used the hydrophobicity and pH sensitivity of 2E4MI to prepare a liposomal drug delivery system with intelligent response function. The system can quickly release drugs in an acidic environment and is suitable for targeted therapy in the tumor microenvironment. Experimental results show that 2E4MI modified liposomes significantly improved the targeting and therapeutic effect of the drug in a mouse model, and the tumor volume was reduced by more than 70%. The study, published in Angewandte Chemie International Edition, provides new ideas for the application of 2E4MI in the delivery of anti-cancer drugs.
Research Trends and Challenges
From the research progress at home and abroad, it can be seen that the application of 2E4MI in drug delivery systems has achieved remarkable results, especially in improving the targeting of drugs, extending drug release time, enhancing drug biocompatibility, etc. It showed obvious advantages. However, the 2E4MI study still faces some challenges:
-
Complex synthesis process: The synthesis steps of 2E4MI are relatively cumbersome and involve multiple chemical reactions, resulting in high production costs. In the future, it is necessary to develop simpler and more efficient synthetic methods to reduce the production cost of 2E4MI and promote its large-scale application.
-
In vivo metabolic pathways are unknown: Although 2E4MI shows good biocompatibility and safety in in vitro experiments, its metabolic pathways and long-term safety in vivo still need further study. In the future, more animal experiments and clinical trials are needed to evaluate the metabolites of 2E4MI in humans and their potential toxic side effects.
-
Multi-discipline cross-cooperation: The application of 2E4MI involves multiple disciplines such as chemistry, materials science, biology, medicine, etc. In the future, it is necessary to strengthen interdisciplinary cooperation to promote 2E4MI in drug delivery systems. Innovative application. For example, combining artificial intelligence and big data analysis to optimize 2E4MIThe structural design and drug delivery strategy improve the intelligence level of drug delivery system.
In short, 2E4MI has broad application prospects in drug delivery systems, but a series of technical and scientific problems still need to be overcome. In the future, with the continuous deepening of research and technological advancement, we believe that 2E4MI will play a more important role in the field of drug delivery and bring more efficient and safe treatment plans to patients.
Future development direction and prospects
As the increasing application of 2-ethyl-4-methylimidazole (2E4MI) in drug delivery systems, future research and development directions will focus on the following aspects to further enhance its medical field Potential and application value.
1. Development of new drug delivery systems
The future drug delivery system will pay more attention to personalization and intelligence to meet the needs of different patients. As a multifunctional drug carrier material, 2E4MI is expected to play an important role in the following types of new drug delivery systems:
-
Intelligent Responsive Drug Delivery System: The pH sensitivity and temperature sensitivity of 2E4MI make it an ideal choice for developing intelligent responsive drug delivery systems. By designing 2E4MI modified nanoparticles, liposomes or gels, accurate drug release in specific environments can be achieved. For example, in tumor microenvironment, pH values are usually low, and 2E4MI modified drug carriers can quickly release drugs under acidic conditions, improving drug targeting and therapeutic effects. In addition, 2E4MI can also be combined with temperature-sensitive materials to develop intelligent delivery systems that can release drugs when body temperature changes, suitable for local administration or combined treatment of thermal therapy.
-
Multimodal Drug Delivery System: Future drug delivery systems will no longer be limited to a single drug delivery method, but will develop in the direction of multimodality. 2E4MI can develop a drug delivery system with multiple functions by combining with other functional materials (such as magnetic nanoparticles, photosensitizers, etc.). For example, 2E4MI modified magnetic nanoparticles can not only achieve targeted delivery of drugs, but also guide the drug to a specific site through an external magnetic field, in combination with magnetothermal therapy or magnetic resonance imaging (MRI). Similarly, a system that combines 2E4MI with photosensitizer can trigger drug release under light to realize photocontrolled drug delivery, which is suitable for the treatment of skin cancer, ophthalmic diseases, etc.
-
Degradable Drug Delivery System: The imidazole ring structure of 2E4MI can specifically bind to enzyme substances to promote the biodegradation of drug carriers. Future research can further explore the interaction mechanism between 2E4MI and different enzymes, and develop specific parts in the body.degraded drug delivery system. For example, 2E4MI modified polymer microspheres can be degraded by specific enzymes in tumor tissue, releasing drugs and reducing damage to normal tissue. This degradable drug delivery system not only improves the safety of the drug, but also avoids the long-term retention of drug carriers in the body and reduces potential side effects.
2. Expansion of clinical applications
At present, the application of 2E4MI in drug delivery systems is mainly concentrated in the laboratory stage. In the future, more clinical trials need to be used to verify its safety and effectiveness, and gradually promote it to clinical applications. The following are several potential directions for 2E4MI in future clinical applications:
-
Cancer Treatment: Cancer is one of the serious diseases around the world, and traditional chemotherapy and radiotherapy methods have major side effects and drug resistance problems. 2E4MI modified drug delivery system can significantly improve the effectiveness of cancer treatment by improving drug targeting and reducing damage to normal tissues. For example, 2E4MI modified liposomes can specifically deliver chemotherapy drugs to tumor cells to avoid damage to surrounding healthy tissues; 2E4MI modified nanoparticles can be combined with immune checkpoint inhibitors to enhance the effectiveness of immunotherapy and help Patients fight cancer better.
-
Treatment of neurological diseases: The treatment of neurological diseases (such as Alzheimer's disease, Parkinson's disease, etc.) has always been a difficult problem in the medical community. Existing drugs are difficult to break through the blood-brain barrier. Causes poor treatment effect. The 2E4MI modified drug delivery system can help the drug enter the central nervous system smoothly and improve the therapeutic effect by enhancing the penetration ability of the drug. For example, 2E4MI modified nanoparticles can bind to nerve growth factors to promote the repair and regeneration of nerve cells, and are suitable for the treatment of neurodegenerative diseases; 2E4MI modified liposomes can deliver anti-epileptic drugs to the brain, reducing drug Systemic side effects to improve treatment compliance in patients with epilepsy.
-
Topical dosing and wound healing: 2E4MI modified gel and microsphere drug delivery systems have broad application prospects in local dosing and wound healing. The hydrophobicity and antibacterial activity of 2E4MI enable it to effectively inhibit bacterial growth and promote wound healing. For example, 2E4MI modified gels can be used for the treatment of wounds such as burns and ulcers, reducing the incidence of infection and accelerating wound healing; 2E4MI modified microspheres can be used for local administration of diseases such as arthritis and osteoporosis. Prolong the time of action of the drug and reduce the frequency of medication use in patients.
3. Multidisciplinary cross-cooperation and technological innovation
2E4MI applications involve chemistry and materialsIn the future, multiple disciplines such as science, biology, and medicine need to strengthen cross-disciplinary cooperation to promote the innovative application of 2E4MI in drug delivery systems. Specifically, you can start from the following aspects:
-
Artificial Intelligence and Big Data Analysis: With the help of artificial intelligence and big data analysis technology, the structural design and drug delivery strategies of 2E4MI can be optimized. For example, machine learning algorithms predict the interaction of 2E4MI with different drug molecules, and screen out excellent drug combinations; use big data to analyze individual differences in patients, formulate personalized drug delivery plans, and improve treatment effects.
-
3D printing technology: The application of 3D printing technology in the field of drug delivery is developing rapidly. In the future, 2E4MI and 3D printing technology can be combined to develop drug delivery devices with complex structures. For example, using 3D printing technology to prepare 2E4MI modified drug stents, personalized drug delivery devices can be customized according to the patient's condition to achieve precise treatment; 3D printed 2E4MI modified microneedle arrays can be used for percutaneous administration, reducing the patient's Pain improves the absorption efficiency of drugs.
-
Gene Editing and Cell Therapy: With the rapid development of gene editing technology and cell therapy, 2E4MI can combine with these emerging technologies to develop more advanced drug delivery systems. For example, 2E4MI modified nanoparticles can be used to deliver CRISPR/Cas9 gene editing tools to achieve accurate editing of pathogenic genes; 2E4MI modified liposomes can be used to deliver CAR-T cells, enhancing the targeting of immune cells and Killing ability, suitable for cancer immunotherapy.
Conclusion
In short, 2-ethyl-4-methylimidazole (2E4MI) has broad application prospects in drug delivery systems. Future research and development will focus on the development of new drug delivery systems, the expansion of clinical applications and the intersection of multiple disciplines. Cooperation and technological innovation are underway. Through continuous exploration and innovation, 2E4MI is expected to play a more important role in the medical field and bring more efficient and safe treatment plans to patients. We look forward to more breakthroughs in 2E4MI in future research to benefit more patients.
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : :
Extended reading:https://www.newtopchem.com/archives/44742
Extended reading:https://www.newtopchem.com/archives/1686
Extended reading: https://www.bdmaee.net/wp-content/uploads/2022/08/ 44.jpg
Extended reading:https://www.bdmaee.net/polycat-31-polyurethane-spray-catalyst-polycat-31-hard-foam-catalyst-polycat-31/
Extended reading:https://www.bdmaee.net/wp- content/uploads/2021/05/2-10.jpg
Extended reading:https:/ /www.newtopchem.com/archives/577
Extended reading:https:/ /www.bdmaee.net/127-08-2/
Extended reading:https: //www.bdmaee.net/9727-substitutes/
Extended reading:https://www.newtopchem.com/archives/954
Extended reading:https://www .bdmaee.net/wp-content/uploads/2021/05/2-5.jpg
Comments